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Abstract 
Statistics in the United States (US) have shown an increase in the prevalence of Cardiovascular 
Disease (CVD) or risk for developing CVD. Approximately 78 million American adults, 20 
years and older, have hypertension, 31.9 million have elevated serum cholesterol levels, and 68.2 
million use tobacco products. Within California, San Francisco (SF) was ranked 8th among 
counties with adult residents that have CVD. It is estimated that approximately 1.02% of these 
individuals will have a stroke each year and 16.25% will die from stroke. Of those that survive, it 
is estimated that at least half will develop neurologic deficits, and at least a third will develop 
post-stroke depression (PSD). The high prevalence of post-stroke depression (PSD) greatly 
influences stroke survivor mortality, hospital length of stay (LOS), and Quality of Life (QOL) 
further fueling the projected rise of indirect annual costs associated to the loss of productivity of 
stroke survivors and ongoing healthcare costs. Despite best practice recommendations and 
guidelines from health agencies, current stroke care processes of stroke care facilities deviate 
from these recommendations and lack the inclusion of a post-stroke neuropsychiatric sequelae 
protocol or screening measure that leaves PSD undetected and untreated. This project aimed to 
implement the inclusion of a depression screening measure and (pharmacologic and non-
pharmacologic) intervention in the current stroke care processes of a 395-licensed bed, urban, 
general acute care hospital (GACH) located in the downtown Tenderloin area of San Francisco, 
California. Despite the low volume of stroke patients admitted during the 3-month period, the 
project was moderately successful on multiple levels. The project produced the intended 
outcomes of cost-effective staff training and education on the timely administration of PSD 
screening measures and intended pharmacological interventions. It was able to moderately raise 
nurses’ comfort levels in the administration of BH screening questions and answering questions 
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related to its use. Nurses reported moderate increase in confidence on the overall clinical utility 
of PSD screening as part of stroke care processes. The project’s success on improving stroke 
outcomes as it relates to timely screening and intervention of PSD was considered low. However, 
there appears to be a strong link between good communication, good training, and staff 
compliance to small tests of change aimed towards improving patient care. Ultimately, 
depression screening and early intervention on post-stroke patients has the potential to provide 
cost savings or cost avoidance equal to $29159.95 over a 3-month period. 
 
Keywords: Post-stroke depression, Patient Health Questionnaire, Patient Health Questionnaire-2, 
Patient Health Questionnaire-9, National Institutes of Health Stroke Scale, cardiovascular 
disease, neuropsychiatric sequelae, selective serotonin-reuptake inhibitors, cognitive behavior 
therapy 
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Depression Screening and Early Intervention on the Post-Stroke Patient 
Section I: Background Knowledge 
Recent statistics of cardiovascular health in the United States (US) show an increase in 
the prevalence of cardiovascular disease (CVD) or risk for developing CVD. Approximately 78 
million American adults, 20 years and older, have hypertension, 31.9 million have elevated 
serum cholesterol levels (>240 mg/dl), and 68.2 million use tobacco products. For children 
between the ages of 2 to 19 years old, 23.9 million are considered overweight and obese while 
12.7 million are obese (Go et al., 2014), putting them at risk of developing CVD later in life. 
Approximately 800,000 of these individuals will have a stroke episode each year (Go et al., 
2014) and 130,000 will die from stroke (Kochanek, Xu, Murphy, Miniño, & Kung, 2011). Of 
those that survive a stroke episode, at least half will develop neurologic deficits (Phipps, 1991). 
Neurologic symptoms are the primary cause of disability among stroke survivors. These long-
term residual impairments are debilitating and negatively affect the quality of life (QOL) post-
stroke. However, the concurrent development of neuropsychiatric symptoms on post-stroke 
patients can further complicate post-stroke outcomes. Between 33 to 50 percent of stroke 
survivors will develop clinically significant depressive symptoms at any stages of recovery 
(Hackett, Yapa, Parag, & Anderson, 2005; Robinson, Starr, Kubos, & Price, 1983).  
Stroke is a life changing and debilitating event, but a combination of stroke and 
depression can be particularly devastating. The high prevalence of PSD greatly influences stroke 
survivor mortality, hospital length of stay (LOS), and QOL further fueling the projected rise of 
indirect annual costs associated to the loss of productivity of stroke survivors and ongoing 
healthcare costs, from $33.65 billion to $56.54 billion within the next 20 years (Ovbiagele et al., 
2013).  
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Overview of Relevant Theories 
 Numerous epidemiological, clinical, neuroimaging and neuropathology studies have been 
conducted in an attempt to explain the definite etiology of PSD. The psychological hypothesis 
for PSD suggests that social and psychological stressors associated with stroke triggers the 
depressive episode of stroke survivors (Fang & Cheng, 2007). The psychosocial framework 
views depression as resulting from the interplay of several domains of variables, including 
personal and environmental resources, environmental stressors, and the individual's appraisal and 
coping responses to specific stressful events (Billings & Moo, 1982).  Similar to primary 
depression, it is postulated that severity and frequency (i.e. more than one stroke episode) 
increase the prevalence of PSD. Phipps (1991) suggested that post-stroke neurologic deficits, 
permanence of loss of function and independence, and the stress of undergoing rehabilitation 
predisposes, precipitates, and perpetuates depressive symptoms post-stroke. 
The biological hypothesis of PSD is the most predominant among all of the theories that 
attempt to explain the etiology of the disease. Several researches have utilized the biological 
framework of stroke as means of correlating the following possible mechanisms to the 
development of PSD: (a) lesion location, (b) neurotransmitters mechanism, (c) inflammatory 
cytokines mechanism, and (c) gene polymorphism mechanism (Fang & Cheng, 2007). The site 
of infarct or location of the lesion suggests an organic biological basis for the difference of 
emotional reactions and development of mood disturbance post-stroke, with left-sided cortical 
and sub cortical lesions having a high prevalence for PSD (Rajashekaran, Pai, Thunga, & 
Unnikrishnan, 2013). The ability of the brain to rewire or reorganize itself after injury is also 
believed to precipitate behavioral changes and post-stroke neuropsychiatric sequelae. It is also 
postulated that repair activities within the brain post-stroke can cause PSD through alterations in 
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the microenvironments of the parenchyma that eventually leads to the abnormal release of 
neurotransmitters. An increase in glutamate and decrease serotonin and norepinephrine were 
linked to PSD (Sanchez-Mendoza et al., 2014). The release of multiple inflammatory cytokines 
by the parenchyma such interleukin (IL) 1β, IL-18, and tumor necrosis factor α, were also 
associated with PSD (Fang & Cheng, 2007). A repeat length of polymorphism of Serotonin 
Transporter (SERT) variants of 5-HTTLPR, STin2 VNTR, and rs25531, were all linked to 
depression-susceptibility in people experiencing emotional trauma including PSD (Kohen et al., 
2008).   
Neurobiological Etiology 
 There is currently no definite mechanism that defines the etiology of PSD and it appears 
to be multifactorial in cause. However, several studies have suggested the strong correlation 
between the changes in the microenvironment of the brain and the risk for developing PSD. The 
American Psychiatric Association (2013) classifies PSD as Depressive Disorder Due to a 
General Medical Condition (i.e. stroke). What makes PSD unique from typical depression is the 
necessity for the diagnosing clinician to establish that the mood disturbance is etiologically 
related to the medical condition through a physiological mechanism. Two considerations for 
detecting PSD take its premise from the biological origin of the condition. Diagnosing clinicians 
must assess the presence of a temporal association between onset, exacerbation, or remission of 
the general condition. Onset for PSD can occur 1 day to months post-stroke with depression 
severity strongly correlated with severity of stroke. The second consideration is the presence of 
clinical features that are atypical of primary mood disorders. Although age can be considered a 
risk for PSD with older adults being at higher risk for stroke, other features such as absence of 
family history cannot be factored in to rule out PSD. Majority of the literatures suggest that 
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neurochemical changes independent or triggered by lesion location can trigger PSD – with left 
frontal strokes having the greatest risk compared to right frontal strokes (American Psychiatric 
Association, 2013).  
Onset and Course 
The physiological changes of stroke are well documented. Ischemic changes in cell 
structure begin almost as rapidly as ischemic changes in biochemistry (Gupta, Pansari, & Shetty, 
2002). Stroke involves the formation of blood clots that blocks an artery or a break in a blood 
vessel and prevents oxygenated blood from reaching the brain. Brain damage starts immediately 
when brain cells start to die due to blood deprivation. It is estimated that 2 million brain cells die 
every minute of a stroke (Go et al., 2014). After a stroke episode, new brain cells start to form to 
compensate for the injury and form specialized contacts with other cells. It is postulated that 
these new connections may not always be functional or communicate properly with neighboring 
cells and other brain structures. The cascade of changes within the brain structure and its’ 
biochemistry post-stroke are associated to both post-stroke recovery and risk for developing PSD 
and other neuropsychiatric disorders. The actual onset of PSD remains unclear and varies from 
patient to patient. It is estimated that between 33 to 50 percent of stroke survivors will develop 
clinically significant depressive symptoms at any stages of recovery (Hackett, Yapa, Parag, & 
Anderson, 2005; Robinson, Starr, Kubos, & Price, 1983). Most depressive symptoms manifest 
during the acute phase post-stroke and become more pronounced during acute rehabilitation, 
days to weeks after stroke, with some experiencing depressive symptoms years post-stroke. 
However, some patients show very subtle behavioral changes or may even be asymptomatic 
during hospitalization and rehabilitation, that results in the under-diagnosis of PSD. (Robinson, 
et al.,1983).  
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Stroke Severity Measure 
 Currently, the National Institutes of Health Stroke Scale (NIHSS) is the most widely used 
clinical assessment tool to evaluate post-stroke neurologic status. The NIHSS is a 15-item 
assessment tool that evaluates the consequence of acute infarct on the following: (a) levels of 
consciousness, (b) language, (c) neglect, (d) visual-field loss, (e) extraocular movement, (f) 
motor strength, (g) ataxia, (h) dysarthria, and (i) sensory loss (National Institutes of Health, n.d.). 
The following scores of the NIHSS are interpreted as follows: (a) 0 for no stroke symptoms, (b) 
1 to 4 for having minor stroke, (c) 5 to 15 for moderate stroke, (d) 16 to 20 for moderate to 
severe stroke, and (e) 21 to 42 for severe stroke. The NIHSS is a simple and reliable tool that can 
be administered by clinicians at the bedside regularly, and has been shown as good predictor of 
both short and long-term stroke outcomes.  
Treatment and Care 
Currently, there is no treatment specific to PSD. Historically, the main focus of post-
stroke recovery and conventional stroke care were geared towards rehabilitation. Post-stroke 
rehabilitation takes its premise from the principles of neuroplasticity, the ability of the brain to 
“rewire” to retrain itself to perform everyday functions through repetition of tasks. However, the 
changes in the brain after a stroke are much more complex than this. Imbalances in brain 
chemistry can lead to the development of a concurrent psychiatric condition. Studies have shown 
that there is a negative correlation between severity of depression and 5HT2 receptor binding in 
the left temporal cortex in left-sided stroke and low levels of CSF 5H1AA, the principle 
metabolite of 5HT in PSD (Ramasubbu, Flint, Brown, Awad, & Kennedy, 1999). Randomized 
trials show that antidepressants, particularly selective serotonin uptake inhibitors (SSRI), are 
effective in the treatment of PSD (Gupta et al., 2002). Citalopram and fluoxetine have proven 
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efficacy in the treatment and management of depression among stroke survivors. However, since 
the etiology of PSD is not limited to the biological model and is considered multifactorial, a 
multidisciplinary approach and the inclusion of several treatment modalities (e.g. cognitive 
behavioral therapy (CBT), dialectic behavior therapy (DBT), etc.) other than pharmacologic 
interventions may increase the chances for depression remission.  
Guidelines and Recommendations 
 As the number of stroke cases each year increases and new research studies regarding 
post-stroke sequelae are published, guidelines to stroke care continually evolve. Several national 
and international organizations recommend the inclusion of PSD screening with stroke care. In 
2011, the Brain Attack Coalition amended its recommendations for the establishment of Primary 
Stroke Centers (PSC), to include new elements that may improve the care and outcomes of post-
stroke patients (Alberts et al., 2011) such as detection and treatment of co-occurring mood 
disorders. Additionally, The Joint Commission (TJC) supports the inclusion of depression 
screening and assessment of cognitive decline and other social implications of stroke during its 
acute phase (Go et al. 2013). Similar recommendations were made by health agencies outside of 
the US. In the United Kingdom (UK), the National Clinical Institute for Stroke recommended 
screening for PSD within the first month post-stroke and review of the patient’s mood and 
behavior (Hart & Morris, 2007). 
Local problem 
In a study Lund and Pheatt (2001), San Francisco (SF) was ranked 8th among California 
counties with adult residents that have CVD and at risk for having a stroke. There are several 
General Acute Care Hospitals (GACH) in SF, at least 5 of which are TJC-certified PSCs, which 
cater to the healthcare needs of SF residents and that of other neighboring counties (Vega, 2014). 
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Despite best practice recommendations and guidelines from several national and international 
health agencies, (with the exception of Comprehensive Stroke Centers) current stroke care 
processes deviate from these recommendations and lack the inclusion of a post-stroke 
neuropsychiatric sequelae protocol or screening measure that leaves PSD undetected and 
untreated. Additionally, because of the decline in reimbursements for BH care, majority of the 
hospitals can no longer afford to offer such services in an inpatient setting. 
Stroke remains one of the most common causes of disability among patients with CVD. 
Designated PSCs and other health facilities caring for stroke patients must explore the 
prevalence of post-stroke neuropsychiatric sequelae in the population that they are caring for and 
should consider adopting measures for screening for PSD and providing appropriate 
interventions. Hart and Morris (2007) examined the compliance of healthcare professionals in 
screening for PSD. Of the 145 hospitals with stroke services examined, 88% had local protocols 
in place for post-stroke psychological assessments. Reported compliance among these hospitals 
was low, with a rate of only 50%. The researchers found it interesting that despite positive 
attitudes of staff toward screening, the average intention to screen was low. The following 
barriers to screening were identified: (a) time pressure, (b) feeling uncomfortable using the 
available tool(s), and (c) concern than screening may trigger the disease or other depressive 
symptoms. Additionally, many providers still believe that most cases of PSD resolves without 
any PSD-specific interventions as post-stroke neurologic deficits improve during the 
rehabilitation phase. 
Intended Improvement Project/Purpose of Change 
 A proposal of change to meet the needs of individuals at risk for developing PSD was 
identified by the project manager to implement in hopes of providing early detection and 
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treatment, for patients admitted in the hospital in an effort to improve stroke outcomes and 
reduce costs associated with stroke care, prolonged rehabilitation, and long-term disability. 
Despite being one of the few hospitals in the city that offer inpatient services for psychiatric and 
behavioral health (BH) disorders, inpatient BH services are only limited to patients actually 
admitted in the Behavioral Health Unit (BHU) while floor consults are reserved only to medical 
patients with acute psychiatric symptoms (e.g. danger to self, danger to others, etc.). In 
collaboration with the project sponsor, organizational leaders, physicians, and staff nurses on 
stroke care areas, the project manager developed a plan to address this gap by introducing a 
standardized screening measure and early intervention for PSD in the hospital’s current stroke 
care processes. The project was approved by hospital’s regional Institutional Review Board 
(IRB) and classified as a quality improvement (QI) initiative and do not meet the criteria for 
human subject’s research under state and federal regulations (see Appendix B). 
Aim Statement 
 As members of the stroke care team, the role of nurses and physicians was providing 
accurate and timely screening for PSD and provide treatment for positive screens. Together with 
nurse volunteers who served as resource nurses, the project manager conducted a small test of 
change, screening patients for PSD in each stroke care areas for a 30-day period. High yield 
areas were identified while low-to-no yield areas were excluded from the project which spanned 
3 months. The project manager monitored and reported bimonthly to the nurse managers and 
project sponsor. The project goal is 90% timely screening for PSD on all admitted stroke patients 
and to provide appropriate intervention(s) for post-stroke sequelae, therefore reducing post-
stroke neurologic deficits as evidenced by improved pre-discharge NIHSS scores and reducing 
the following: (a) falls, (b) hospital LOS, (c) post-stroke depressive symptoms, and (d) hospital 
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readmission. Additionally, the project aimed to improve nurses’ comfort levels in administering 
BH screening measures on patients that are typically considered non-psychiatric or 
psychiatrically well.  
Objectives 
 Nurses working in stroke care areas are responsible for assessing the need for psychiatric 
and behavioral health intervention(s) of patients, utilizing the recommended screening tools (see 
Appendices H and I). These nurses have the responsibility of ensuring that PSD screening is 
administered on all admitted stroke patients. Specific objectives identified as part of the stroke-
care nurse included: (a) identify if the patient meets the criteria for PSD screening through 
review of the most current National Institute of Health Stroke Scale (NIHSS) scores on Facial 
Palsy and Best Language, (b) timely administration of the depression screening tool(s), on the 
3rd day or after 72 hours of hospitalization , (c) concise and timely documentation of the 
patient’s Patient Health Questionnaire (PHQ) score in the organization’s electronic health record 
system (EHR), Cerner, using the Situation-Background-Assessment-Recommendation (SBAR) 
format, and (d) assure that PSD treatment and/or other BH interventions ordered by the physician 
are carried out on a timely manner. 
 Physicians attending to the care of stroke patients had the responsibility of assessing the 
need for psychiatric and/or BH interventions during hospitalization and on the day of discharge. 
Specific objectives identified as part of the attending physician’s responsibilities included: (a) 
timely review of the patient’s PHQ score(s) and nurses’ SBAR entry, (b) order appropriate 
pharmacologic and/or non-pharmacologic intervention, (c) timely request for BH and/or 
neuropsychiatric consult if necessary, and (d) timely documentation of explanation and 
justification for not ordering PSD intervention. 
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 These objectives were discussed with all involved organizational leaders, physicians, and 
staff, to increase compliance to the project and its realization. The success of the PSD screening 
project relied on the enthusiastic participation of staff. The project leader frequently surveyed the 
involved units and engaged staff at least once a week, both during the testing, training, and live 
phases of the project. Since nursing provides the most direct post-stroke care services, it was 
essential to also gain the support of the organization’s Education Department to ensure the 
continuity of the project and that competencies for the use and interpretation of the PHQ tools 
are documented. 
Review of the Evidence 
 Several studies have investigated the effects of depression on the stroke patient and it has 
been found that PSD significantly impacts patient rehabilitation, function, recovery, and quality 
of life (Chen, Guo, Zhan, & Patel, 2006). Additionally, PSD is also associated with increased use 
of healthcare resources (Herrman et al., 2011; Williams et al., 2007). A review of the literature 
was conducted using Fusion and Google Scholar to further support these claims and to identify 
additional studies on stroke and PSD published between 1980 to the present. Search terms 
included stroke, PSD, post-stroke, stroke treatment, stroke rehabilitation, stroke care, and 
depression screening. The search yielded more than 80 articles. Twenty-five articles were 
selected based on content and relevance to the project, while 6 were appraised using an evidence 
table (see Appendix S). 
Validity of Screening Measures 
 Lincoln, Nicholl, and Flannaghan (2003) conducted a cross-sectional study on the 
validity of questionnaires in screening for PSD, mood and other neuropsychiatric sequelae. 
Twenty stroke patients were recruited from hospital wards while an additional 123 were 
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recruited from a randomized control trial of cognitive behavioral therapy (CBT). All 143 
participants completed the following questionnaires: (a) Beck Depression Inventory (BDI), (b) 
Wakefield Depression Inventory (WDI), and (c) General Health Questionnaire-28 (GHQ-28). 
The authors found that patients who met the DSM’s criteria for depression scored significantly 
higher on questionnaires than those patients who were not depressed, with correlational 
variances ranging between 23 to 34%. BDI had an 83% sensitivity and a 44% specificity in 
detecting PSD in relation to the DSM criteria for depression, while WDI had an 86% sensitivity 
and a 50% specificity, and the GHQ-28 had an 81% sensitivity and a 68% specificity. The 
findings of the study emphasized the limitations of standardized assessment measures and the 
variations of prevalence rates among these screening tools on the detection of PSD. The 
researchers concluded that although PSD screening measures are sensitive to PSD, they have low 
specificity. 
 A similar study that aimed to determine the validity of screening measures for detecting 
PSD was contacted by Turner et al. (2011). The researchers aimed to determine internal 
consistency among the following screening tools: (a) Patient Health Questionnaire-2 (PHQ-2) 
and Patient Health Questionnaire-9 (PHQ-9), (b) Hospital Anxiety and Depression Scale 
(HADS), (c) Beck Depression Inventory-II (BDI-II), (d) Distress Thermometer (DT), and (e) 
Kessler-10. Seventy-two participants were recruited in the study, aged 25 to 91 years; all were 
three or more weeks post-stroke. Participants either self-completed each of the screening tools 
using paper or by a touchscreen computer during one appointment. The researchers concluded 
that, apart from the DT, all screening measures performed considerably well in accurately 
detecting PSD and support recommendations on the inclusion of depression screening tools in 
stroke care. 
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Stroke-specific Geriatric Depression Scale 
 Clinicians face the challenge of accurately assessing PSD in a population where the 
disease is complicated by both aging and disability. The elderly population has the highest 
incidence of CVD and risk for stroke. Screening measures for depression are often too lengthy, 
confusing for the elderly, and do not assess for the severity of the disease. Cinamon, Finch, 
Miller, Higgins, and Mayo (2010) conducted a study on the development of a stroke-specific 
depression screening measures for geriatric patients. A 17-item stroke-specific Geriatric 
Depression Scale (SS-GDS) was developed that measured the following PSD symptoms: (a) 
motor, (b) cognitive disability, (c) emotionalism, and (d) depressive symptoms. Ninety-one 
stroke patients, aged 71 and older, all one-year post-stroke, were interviewed using the SS-GDS 
over 3 points and yielded 240 interviews. Of those that screened positive for PSD, the following 
major symptoms for depression were expressed by the participants: (a) worrying about the past, 
(b) being in good spirits, and (c) being hopeful about the future. The researchers also noted that 
PSD symptoms different from typical depression wherein symptoms are more pronounced 3 
months after stroke. 
The researchers concluded that SS-GDs has a 79% reliability in detecting and quantifying the 
severity of PSD, and can have important practical applications for the refinement of stroke care 
processes for the elderly. 
Smiley Diagrams 
 Lee, Tang, Yu, and Cheung (2007) conducted a cross-sectional study on the clinical 
utility of emoticons in screening for PSD. The purpose of the study was to determine the efficacy 
of a simple, non-language-based, culturally neutral, non-verbal, and easy to administer screening 
measure detecting PSD, particularly on elderly patients who suffer multiple functional losses. 
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The tool consisted of 3 enlarged diagrams: (a) a happy face, (b) a flat face, and (c) a sad/tearing 
face. Initially, the emoticon tool consisted of 5 diagrams that included a very happy and a very 
sad face. All 5 diagrams were matched with a 5-point Likert scale. However, older participants 
during the pilot found it difficult to differentiate between the very happy with happy and very sad 
with the sad diagrams. The researchers decided to eliminate the smileys with quantifiers. 
Meeting 5 of the DSM criteria meant that the participant was depressed. Two hundred fifty-three 
participants, aged 50 and older, all monolingual Chinese, and all 1-month post-stroke, were 
recruited from two regional hospitals in Hong Kong.  
The researchers reported varying rates of sensitivity for each emoticon in detecting PSD: 
(a) 75.9% for sad, (b) 98% for flat, and (c) 48.3% for happy. Similarly, varying rates of 
specificity were reported for each emoticon: (a) 77.4% for sad, (b) 18.2% for flat, and (c) 73% 
for happy. Because there was a strong negative correlation between the flat and happy emoticon, 
but there was no such correlation between the flat and sad emoticon, the researchers speculate 
underreporting of the sad emoticon among mildly depressed participants. The researchers 
concluded that the positive predictive value for PSD of the emoticon to slightly exceeds 50%. 
The performance of the visual tool appears promising, not as an alternative to other language-
based tools but as an adjunct tool for screening PSD in patients with low literacy and limited 
linguistic capabilities. 
Single-item Screening Tool 
 Screening tools are often lengthy, redundant, and confusing for patients for which the 
tools are being administered on. With the competing demands in direct patient care areas, 
clinicians often don’t have the time to properly explain the purpose of the screening measure and 
go through each items listed at the pace of the patient is comfortable with. Watkins et al. (2007) 
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conducted a study on the accuracy of a single-item screening tool for detecting PSD. The 
researchers administered the Yale, a screening tool for PSD that only requires a simple “yes” or 
“no” answer to one question, on 540 admitted stroke patients. Screening was administered at two 
points post-stroke: (a) 2 weeks and (b) 3 months. The study found that the Yale had 85% 
sensitivity and 84% specificity in detecting PSD at 2 weeks post-stroke. After 3 months, the Yale 
had 95% sensitivity and 89% specificity, with an overall efficiency of 92% in detecting PSD. 
The researchers also noted that the tool is promising when compared to other multi-item 
screening measures such as the Geriatric Depression Scale (GDS), Hospital Anxiety and 
Depression Scale (GHDS), and the General Health Questionnaire (GHQ). The researchers 
concluded that a single-item tool can satisfactorily detect PSD and recommended the use of the 
Yale when considering the need for further psychiatric and behavioral health interventions. 
However, the researchers also cautioned clinicians in using the Yale on stroke patients with 
moderate to severe cognitive and language deficits, as the tool may produce false results. 
Zung Self-Rating Depression Scale 
 Identification of PSD risk factors is essential to develop specific post-stroke 
neuropsychiatric interventions and preventative strategies during stroke recovery and 
rahbilitation. A cross-sectional study was conducted by Bose and Shah (2012) to determine 
whether depression levels are related to the following: (a) location of stroke, (b) gender, (c) 
cause of stroke, (d) number of arteries involved, and (e) presence of other medical co-
morbidities. Participants in the study were recruited from various hospitals in Mumbai and Navi 
Mumbai. The researchers administered the Zung Self-Rating Depression Scale (ZSRDS) on 100 
stroke patients, all at least two-weeks post-stroke. The ZSRDS is a 20-item depression screening 
tool that has a 93% predictive value of detecting depression when compared other commonly 
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used screening measures. The researchers found that severity of depression is higher in right-
sided stroke patients. Additionally, the researchers reported that there is no significant 
relationship for stroke severity on gender, cause of stroke, number of arteries involved, and 
presence of other medical co-morbidities. The researchers also support the active screening for 
PSD beyond the acute phase post-stroke and extend out in rehabilitation. 
Conceptual/Theoretical Framework 
 The theoretical framework for this project is based on Betty Neuman’s Systems Theory. 
Neuman’s theory postulates that wellness is the condition in which all system parts and subparts 
are in harmony with the whole system of an individual. The following basic assumptions of 
Neuman’s Systems Theory (Neuman & Fawcett, 2010) were utilized: 
 Each patient system is a unique composite of factors and characteristics within a range of 
responses contained in a basic structure. 
 Many known, unknown, and universal stressors exist. Each differ in their potential for 
upsetting a client's usual stability level. 
 Each patient has evolved a normal range of responses to the environment referred to as 
the normal line of defense. It can be used as a standard by which to measure health 
deviation. 
 The particular inter-relationships of patient variables can, at any point in time, affect the 
degree to which a client is protected by the flexible line of defense against possible 
reaction to stressors. 
 When the flexible line of defense is incapable of protecting the patient against an 
environmental stressor, that stressor breaks through the line of defense. 
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 The client is a dynamic composite of the inter-relationships of the variables, whether in a 
state of illness or wellness. Wellness is on a continuum of available energy to support the 
system in a state of stability. 
 Each patient has implicit internal resistance factors known as LOR, which function to 
stabilize and realign the patient to the usual state of wellness. 
 Primary prevention is applied in patient assessment and intervention, in identification and 
reduction of possible or actual risk factors. 
 Secondary prevention relates to symptomatology following a reaction to stressors, 
appropriate ranking of intervention priorities, and treatment to reduce their noxious 
effects. 
 Tertiary prevention relates to adjustive processes taking place as reconstitution begins, 
and maintenance factors move them back in a cycle toward primary prevention. 
 The patient is in dynamic, constant energy exchange with the environment. 
Similar to the concepts of the life cycle of project management, Neuman developed a 
sequential nursing process for problem solving. The 6 steps in Neuman's Systems Model nursing 
process was also used as the framework project development and implementation: (a) 
assessment, (b) diagnosis through data collection, (c) goal setting, (d) planning the intervention, 
(e) implementation of the plan, and (d) evaluation (Neuman & Fawcett, 2010). 
 
 
 
Section III: Methods 
Ethical Issues 
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 The project manager considered the following ethical principles throughout the course of 
this project: (a) beneficence and non-maleficence, (b) patient autonomy, and (c) social justice. A 
project statement of determination was submitted to the USF DNP department and the project 
site’s IRB for review. The project was determined as a QI project and did not meet the criteria 
for human subjects’ research under state and federal regulations. 
Byars and Jorge (2015) conducted a study to review the ethical issues and implications 
for healthcare providers on the detection of PSD.  The neuropsychiatric sequelae of stroke may 
include symptoms (e.g. apathy, anxiety, irritability, and impulsivity, etc.) that overlap with a 
major depressive episode, mood disorder, post-traumatic stress disorder (PTSD), or even minor 
depression.  Post-stroke neuropsychiatric disorders such as PSD do not occur exclusively as an 
impaired adjustment reaction to loss of functioning and increased responsiveness of one’s 
mortality. The researchers found that patients with PSD are at risk of committing suicide up to 5 
years after a stroke episode and approximately 7% will die of suicide. Healthcare providers 
involved in the care of stroke patients need to identify and differentiate symptoms of PSD from 
other neuropsychiatric disorders. The research provided several aspects of ethical dilemma that 
healthcare providers encounter when caring for post-stroke individuals: (a) beneficence and non-
maleficence, (b) patient autonomy, and (c) equity.  
 Healthcare providers who introduce and administer health screening measures and 
interventions to patients who have not requested them (nor have prior knowledge of their 
availability) have the added responsibility of making sure that the benefits outweigh any possible 
harm. PSD screening is not part of conventional stroke care. Acutely ill patients are already at an 
emotionally vulnerable state due to numerous variables related to their hospitalization (e.g. 
possible loss of independence, change in environment, etc.). Additionally, the societal stigma 
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associated with mental illness further complicates patient engagement. Family members may 
became defensive or dismissive during the initiation of the screening process and opt for the 
patient to not be screened for PSD during hospitalization. The increase awareness on the risk of 
developing or having post-stroke neuropsychiatric disorder, such as PSD, may prove distressful 
to both patients and family members. Additionally, there is also the possibility that patients may 
minimize symptoms to avoid being stigmatized or complicating their post-stroke care. 
Healthcare providers unfamiliar or have limited experience in the use of behavioral health 
screening measures may fear inducing unwarranted emotional distress to patients and family 
members, or furthering post-stroke apathy and irritability. However, screening typically has no 
impact on the patient’s risk of developing the disorder that is being screened for (Association of 
Faculties of Medicine of Canada, n.d.). 
 The role of the project manager and staff nurses is to introduce PSD screening that 
emphasize on expected improvement in stroke outcomes and not coerce participation. Explaining 
the purpose of administering the screening measure in a therapeutic manner assures that 
informed consent is properly obtained. Rather than overtly campaigning for population results 
and evidence, emphasizing individual benefits of early screening and intervention for PSD 
allows for the patient to have realistic expectations on the risk, intervention, and outcomes. 
Healthcare providers must balance the duty of doing no harm and respecting the patient’s choice. 
To avoid unintentionally dissuading patients, screening nurses are instructed to disclose the 
following prior to screening: (a) PSD screening is currently only a recommendation and not a 
mandate for PSCs, and (b) the PSD measure is a pilot project. 
Non-native English speakers are less likely to be able to participate in the screening 
process in the absence of an English-speaking family member or certified language interpreter. 
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The project site cares for a large percentage of monolingual Chinese and Russians. Because of 
this disadvantage, non-English speakers are at risk of not being afforded accurate and timely 
screening and intervention for PSD. Hospitals and other healthcare organizations must make sure 
that they have resources in place such as certified language interpreters (onsite or via phone) to 
help in translating the screening questions. Using non-certified staff may lead to mistranslation 
while using friends and family members may result in the patient under-reporting depressive 
symptoms. 
Setting 
The setting for this project is a 395-licensed bed, urban, GACH located in the downtown 
Tenderloin area of San Francisco, California. The hospital is certified by The Joint Commission 
(TJC) as a Primary Stroke Center (PSC), and is committed to providing the most up-to-date and 
evidenced-based stroke care. An average of 10 stroke patients per month are admitted through 
the Emergency Department (ED), while the hospital’s Acute Rehabilitation Unit (ARU) also 
receives an average of 10 post-stroke patients from other facilities. 
Along with conventional stroke care, patients are routinely screened for stroke-related 
neurologic deficits using the NIHSS (see Appendices I to K). The NIHSS is a 15-item, clinical 
assessment tool used by trained clinicians to quantify the severity, determine intervention, and 
predict outcomes of stroke patients. Impairments concerning several aspects of brain functioning 
such as consciousness, vision, sensation, movement, speech, and language are given a score. A 
baseline NIHSS score of 21 or more is classified as a severe stroke (National Institute of 
Neurologic Disorders & Stroke, n.d.). With the exception of the BHU, all nurses in the project 
setting are “stroke-certified”, with training and validated competencies in rendering evidence-
based care to stroke patients, including the use of the NIHSS. Stroke severity is assessed on 
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admission and discharge, in the ED, Medical-Surgical Unit (MSU), and ARU. NIHSS is 
completed on admission, discharge, and every shift (8 hours) for all stroke patients in the 
Intensive Care Unit (ICU). NIHSS scores are documented in the hospital’s electronic healthcare 
record (EHR) system, using the Situation-Background-Assessment-Recommendation (SBAR) 
format. 
The progression of inpatient stay is dependent on the severity of stroke. From the ED, a 
patient may be admitted to the ICU and transferred to the MSU when more stable, or may also be 
admitted directly from the ED to the MSU. The stroke patient progresses from the MSU to ARU, 
with an average length-of-stay (LOS) of 10 to 14 days. Post-stroke patients requiring long-term 
care and rehabilitation are transferred to a Skilled Nursing Facility (SNF) while those with little 
to no apparent neurologic deficits are discharged home. The ARU also receives an average of 10 
post-stroke patients from other facilities with an average LOS of 7 to 14 days. 
Planning the Intervention 
The inclusion of a depression screening measure in the project site’s current stroke care 
processes required extensive literature review from various online databases necessary to 
increase the project manager’s knowledge on stroke and post-stroke neuropsychiatric sequelae. A 
strength-weakness-opportunities-threats (SWOT) analysis was conducted to gauge whether 
project objectives were attainable by identifying favorable and unfavorable internal and external 
variables (see Appendix M). Based on the reviewed literature, SWOT analysis, and the project’s 
theoretical framework, the project manager had 2 underlying assumptions: (a) at least one-third 
of admitted stroke patients will screen positive for PSD, and (b) any meaningful change is often 
met with resistance. 
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The project manager also developed a Gantt chart (see Appendix E) to create a timeline 
for project milestones and develop realistic and achievable deadlines for deliverables. This Gantt 
chart was used to help monitor whether the project was moving as projected. Due to several 
unforeseen events (e.g. loss of project sponsor, etc.), the timeline was revised and adjusted 
accordingly to ensure that the project moved forward. Additionally, the sequence project of 
deliverables was determined by developing a Work Breakdown Structure table (see Appendix 
D). 
Narrative of Responsibilities and Work Breakdown Structure 
 A formal diagram for the decomposition of the project’s deliverables was developed (see 
Appendix C). Breaking down the project into small manageable components was necessary to 
identify each component’s hierarchy and ensure prioritization of resources. The precursors and 
mutually exclusive and co-dependent elements of each components were identified by 
developing a project resource requirements table (see Appendix D). The work breakdown 
structure is summarized as follows: 
 Review PSD literature: guidelines, etiology, and screening measures 
 Identify of validated depression screening measure  
 Map the current stroke care workflow 
 Perform a gap analysis 
 Map the proposed PSD screening workflow 
 Pre and post-live survey and review results 
 Create tool kit 
 Train resource nurses 
 Identify high volume units 
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 Pilot in stroke care areas: ED, ICU, MSU, and ARU 
 Train stroke care nurses (end-users) 
 Print screening tool and assemble resource binder 
 Go-live on stroke care units 
 Data Mining and project Evaluation 
 Present findings to organizational leadership 
 Integrate findings into DNP paper 
 Submit DNP with revisions and present project to committee 
Description of Project Resource Requirements 
 The project manager identified a designated PSC to serve as the site for project 
implementation. The project manager contacted the hospital’s Nursing Education Director and 
submitted the following documents required from student interns: (a) criminal background 
check, (b) health clearance and immunization records, (c) student’s resume, and (d) preceptor’s 
(DNP chairperson) resume. Additionally, a project prospectus was submitted for review and 
cleared by the hospitals’ IRB. 
 This project required a project sponsor to serve as a liaison between the project manager 
and organizational stakeholders. The project sponsor also served as an advisor/consultant by 
helping the project manager navigate around encountered and potential barriers, identifying 
stakeholders, and reviewing hospital policies and processes related to stroke care. The project 
volunteered thirty minutes to an hour of his/her time with biweekly meetings or email 
correspondence with the project manager. Throughout its course, the project had a total of three 
different project sponsors. 
DEPRESSION SCREENING AND EARLY INTERVENTION  30 
 
A significant portion of the project’s resource requirements included a dedicated number 
of hours spent in all key phases of the project: (a) research, (b) testing, (c) staff training, (d) go-
live, and (e) evaluation. The project manager participated in the new hire orientation on the use 
of the hospital’s EHR system and was given student access for conducting chart reviews and 
audits. The project manager spent a combined 535 hours in all stages of the project.  
This project required one physician champion that supports the inclusion of a PSD 
screening measure on stroke care. The project manager and the ARU nurse manager met with the 
lead stroke care physician who agreed to support the project. Additionally, the physician 
champion directed the project manager to research articles relevant to PSD screening. 
 This project required at least one resource nurse to administer the PHQ tools for a month 
on each identified stroke care areas: (a) ED, (b) ICU, (c) MSU, and (d) ARU. Resource nurses 
were trained by the project manager on the use of the screening measures. Screening was 
conducted during the resource nurses’ regular shift concurrent with routine patient care. No 
additional compensation was provided and resource nurses were considered volunteers. 
However, these nurses received “project hours” as part of their staff nurse III/IV portfolio. 
 In addition to the resource nurses, unit clerks were also tasked in making sure that new 
stroke patients are logged into the project’s resource manual, and collected and filed all 
completed screening forms in the patient’s paper chart.  
 All of the involved staff have been HIPPA trained and are compliant prior to the start of 
related project activities. 
Communication Responsibilities 
 The success of this project involved regular and effective communication between the 
project manager and organizational stakeholders. The project manager had responsibilities in 
DEPRESSION SCREENING AND EARLY INTERVENTION  31 
 
communicating with members the essential elements of successful PSD screening and 
intervention. The project manager met with nurse managers and the project sponsor bi-weekly 
and corresponded with them via email as needed to give status updates on each phases of the 
project. Similarly, the project manager met with resource nurses bi-weekly. 
Since the screening tool is not available in the organization’s EHR system, a strong emphasis 
was placed on the timely screening for PSD of all admitted stroke patients by putting up 
informational flyers on the nurses’ stations and staff break rooms on all stroke care areas. The 
project manager’s contact information was made available for staff if questions regarding the 
project arise. 
 Baseline data on staff’s comfort levels and perceptions on the use of BH screening tools 
were collected via a self-administered survey form handed-out during nurses’ huddles and were 
also available in each of the stroke care areas project resource binder. Nurses were also asked to 
complete a similar, but slightly modified, post-live survey form. Nurses were provided training 
and education on the administration of the PHQ tools via a “read and sign” project resource 
binder. The project manager and the resource nurses conducted the staff in-service and signed-
off nurses who completed the in-service from the unit roster. Feedback from staff were collected 
and reviewed by the project manager. Survey results and feedback were also communicated to 
the nurse managers and project sponsor for review and further feedback. 
 Nurses refer to the unit’s census to identify stroke patients and refer to the EHR system 
for admission dates and most current NIHSS scores. Charge nurses and resource nurses also 
remind staff of patients which are due depression screening. The results of the screen are 
communicated to the attending provider verbally and by charting in the EHR. 
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 Upon completion of the data analysis, the project manager will present the outcomes of 
this QI improvement project to his Doctor of Nursing Practice (DNP) chairperson and committee 
members.  
Implementation 
The implementation of the project was supported by the elements and timeline 
established in project’s work breakdown structure, resource requirements and Gantt chart (see 
Appendices C to E). Based on these documents, 8 distinct phases were identified for the 
successful completion of the project. These phases included: (a) review of evidence, (b) 
workflow mapping and gap analysis, (c) identification and training of resource nurses, (d) pilot 
testing, (e) training of staff nurses, (f) assembly of project live materials, (g) project go-live, and 
(h) post-live and evaluation.  
The project manager conducted a comprehensive literature review which was used in 
identifying articles related to PSD. The author synthesized current PSD screening and 
intervention guidelines, studies on the etiology of typical depression and PSD, PSD screening 
studies and validated tools, intervention and treatment modalities. A study of the current stroke 
care workflow was also conducted in consultation with the project sponsor, the stroke 
coordinator, and nurse managers of stroke care units. From this, a gap analysis was completed 
and it was identified that there is no standardized process to screen for and document PSD. A 
new workflow was proposed that highlighted the inclusion of the PHQ-2 and PHQ-9 depression 
screening tools (see Appendix G). PSD screening is due after 3 days or 72 hours post-hospital 
admission. With input from the stroke coordinator, items 4 (Facial Palsy) and 9 (Best Language) 
of the NIHSS were used to determine the exclusion criteria for PSD screening. Stroke patients 
with complete facial paralysis and/or severe to global aphasia were excluded until an 
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improvement in the said NIHSS items are observed. Additionally, patients with pre-existing 
depression and other mood disorders who were already on an antidepressant regimen were also 
excluded. Nurses administered the PHQ-2 (see Appendix H). If the patient scored 3 or higher on 
the PHQ-2, nurses proceed in administering the PHQ-9 (see appendix I). If the patient scored 10 
or higher on the PHQ-9, then this was indicative of a “positive” screen for depression. Nurses 
documented their findings in the patient’s EHR using the SBAR format. The attending provider 
reviewed the clinical note and decided on an appropriate intervention (e.g. BH consult, to start on 
an antidepressant, outpatient BH follow-up, psychotherapy, etc.). Providers documented their 
clinical impression in patient’s EHR. The completed depression screening tools were filed in the 
patient’s paper chart and are electronically scanned by medical records after the patient had been 
discharged. 
The project manager capitalized on the hospital’s clinical nurse ladder program and 
consulted with nurse managers in identifying potential resource nurses (staff nurse III/IVs) for 
the project. These nurses served as volunteers and were trained by the project manager in the 
administration of the PHQ-2 and PHQ-9. Pilot testing on high-volume stroke care units was 
conducted for 4 weeks. Together with the resource nurses, the project manager was able identify 
additional barriers and made appropriate changes to the proposed workflow. Both the ICU and 
ED were removed the project because of low-yield results (see Appendix P). The project 
officially went live in June 2015. Data mining for the first 3-months after implementation was 
conducted. Staff was again asked to complete a survey. Project evaluation began on month 2 and 
extended to 8 more weeks after the project go-live.  
Results and findings were incorporated in the project manager’s paper and submitted to 
his DNP committee for review. Revisions will be made on this paper based on the committee’s 
DEPRESSION SCREENING AND EARLY INTERVENTION  34 
 
feedback and will be re-submitted after 2 weeks. A formal presentation of the project will follow 
contingent upon approval of the DNP committee. 
Barriers to Implementation 
 The project had several set-backs since inception. After a review of the hospital’s EHR 
system, the project manager identified the lack of a validated depression screening tool for 
clinicians. One of the initial objectives of this project was to have the PHQ-2 and PHQ-9 to be 
built into the EHR system prior to going live with the project. The project manager intended to 
have an automated clinical alert for positive screens. Unfortunately, the project site is part of a 
larger hospital network and any “build requests” will be system-wide and will have to go through 
the corporate office. Approval for build requests take at least 6 months to a year, with an 
additional 3 months for building and testing. After consultation with the project sponsor and the 
hospital’s clinical informatics educator, the project manager decided to abandon the electronic 
format and instead opted to have the screening tools on a paper. The proposed workflow was 
revised to reflect this change. Additionally, a Strength-Weakness-Opportunity-Threat (SWOT) 
analysis (see Appendix M) was developed based on the following identified barriers for project 
implementation: 
 Changes in Organizational Leadership 
Two weeks after starting the program, the hospital’s Stroke Coordinator left the 
organization. The project manager was able to meet and consult with her only once prior 
to her departure. The Stroke Coordinator position remains vacant to date. Half way 
through the project’s testing phase, the Director of Critical Care, who served as the 
project sponsor and clinical liaison, and the Chief Nursing Officer (CNO) were 
unexpectedly terminated by the hospital’s executive leadership. The project was on hold 
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for approximately 2 months until a new sponsor was identified. The former project 
sponsor suggested that the project manager contact the hospital’s Director of Nursing 
Education to discuss the future of the project. Fortunately, The Director of Nursing 
Education agreed to be the new project sponsor. Two months after, the new project 
sponsor also left the organization. Again, the project was on hold for approximately 2-3 
weeks until a new sponsor was identified. This dilemma was communicated to the DNP 
committee as the project’s progress was again in jeopardy. One of the committee 
members suggested that the project manager contact the hospital’s Director of Clinical 
Informatics in hopes of gaining new sponsorship. The Director of Clinical Informatics 
agreed to be the new (3rd) project sponsor. Two months later, the Director of 
Rehabilitation Services also left the organization. 
 Low Patient Volume 
Being a small-sized hospital in an area with several bigger PSCs, the hospital only 
receives an average of 10 stroke cases per month. Convincing internal stakeholders, 
particularly providers, to accept a change in current stroke care workflow will be 
difficult. Additionally, the medical units rely on BH providers for BH consults. Often 
times, BH consults are not completed in a timely manner since the hospital only has two 
psychiatrists, who also serve as attending providers for the inpatient BHU. 
 Low Yield 
After discussion with the hospital’s stroke coordinator, it was determined that pre-
existing depressive and other mood disorders, complete facial paralysis, and severe 
aphasia will serve as the exclusion criteria for post-stroke depression screening, lowering 
potential number of depression screening candidates. 
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 Change Fatigue and Staff Compliance 
On July 2014, the hospital had its PSC re-certification survey from TJC. It was 
found that nurses were non-compliant in routine completion of the NIHSS on stroke 
patients. As part of the hospital’s corrective plan of action, all nurses were re-educated on 
the use of NIHSS. According to one of the nurse resources, “It will be difficult to expect 
nurses to do something new when compliance is already low in something that they 
should be doing in the first place”.  
Methods of Evaluation 
Time and Cost Summary 
 The project manager had a time-limited role in implementing the project. A Gannt chart 
(see Appendix E) was developed to map out a timeline for project milestones. This helped the 
project manager to navigate around time constraints and monitor whether deadlines for 
deliverables were being met as projected. Due to several unforeseen events (e.g. loss of project 
sponsor, etc.), several components of the chart was revised and adjusted accordingly to reflect 
changes in deadlines.  Approximately 36 weeks was spent conducting review of literature related 
to stroke and PSD. The project manager spent 4 weeks in identifying an implementation site and 
project sponsorship, and obtaining clearance from the site’s IRB. An additional 8 weeks was 
spent meeting with key stakeholders. Training and testing took a combined 12 weeks to 
complete. The project went live on June 2015 and was supported by the project manager and 
resource nurses for 8 weeks. Staff surveys were conducted pre and post-live for 2 weeks each. 
Review of data and project evaluation took 12 weeks. The project was completed at the end of 
October 2015.  
Cost-Benefit Analysis / Financial Outcomes 
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The project manager developed a formal budget with estimated breakdown of expenses 
(see Appendix F). Estimates were compared with actual costs to determine variances. The budget 
for direct costs was $1,080.00 while actual direct costs were $978.50. Variance for direct costs 
was 9.39%. The budget for indirect costs was $500.00 while actual indirect costs were $536.75. 
Variance for indirect costs was -7.35%. An estimate of the opportunity costs for those involved 
in the project was also included in the budget, merely as a reference. Opportunity cost for 535 
project hours was $46,909.60 .  
Financial outcomes were to be demonstrated by total project (direct and indirect) 
expenses versus improved outcomes such fall episodes, LOS, and hospital readmission rate. 
However, the process of measuring financial outcomes was more difficult than originally 
expected due to accounting structures and billing processes. The sudden departure of the 
hospital’s Stroke Coordinator and Director of Rehabilitation Services, individuals who had 
access to the necessary data, further complicated analysis of patient outcomes and translating 
them into financial outcomes. A summary table was developed to present estimated cost savings 
and cost avoidance related to decrease in LOS and episodes of fall, for stroke patients who 
screened positive for PSD and started on an SSRI (see Appendix T). According to Medi-Cal’s 
Diagnostic Related Group (DRG) pricing calculator, base payment for stroke care is $17,415.00 
for an average LOS 7.65 (California Department of Healthcare Services, 2015). The estimated 
savings over a 3-month period for decrease in LOS was $6,140.11 for the MSU and $6,032.64 
for the ARU. According to a study conducted by Exel et al. (2003), a single fall episode of a 
stroke patient during hospitalization increases LOS by 71%. Based on this information, it is 
estimated that savings over a 3-month period for 0 episodes of fall was $8.079.80 for the MSU 
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and $10,422.65 for the ARU. The total estimated cost savings produced by the project over a 3 
month period was $30,376.20. 
Evaluation Criteria 
This project was intended to involve all stroke care areas in the hospital in screening for 
PSD on all admitted stroke patients. The evidence surrounding depression screening and positive 
outcomes of early PSD intervention is strong but relied heavily on the involvement of a larger 
population group to prove its short-term and long-term efficacy. In order for the project manager 
to successfully implement this project, certain elements had to be removed (i.e. electronic 
version of the tool in the EHR) and reduction in scope had to be initiated (i.e. exclusion of ICU 
and ED after testing). Full evaluation of the project through staff surveys and patients’ chart 
review was based on the following: (a) proficiency of resource nurses in educating other nurses 
on the use of the PHQ depression screening tools, (b) accurate and timely administration of PHQ 
tool(s) on stroke patient meeting the criteria for PSD screening, (c) nurses’ perception on the 
clinical utility of BH screening measures and their comfort levels in administering such tools, (d) 
clinical utility of BH screening measures for post-stroke patients as it relates to  LOS, hospital 
readmission, falls, and pre-discharge NIHSS scores. Because this program is in its beginning 
stages, it will require ongoing evaluation and refinement in processes. 
Analysis 
Evidence of the successful implementation of the project towards the goal of early 
screening and intervention for PSD on stroke patients was measured in 3 different stages: (a) pre-
live, (b) live, and (c) post-live. Results of pre and post-live staff surveys (see Appendices N and 
O) and the screening and intervention results (see Appendix P) were reviewed and analyzed. 
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A total of 76 nurses completed the pre-live survey. A high number of nurses expressed 
moderate to high comfort levels in administering BH screening tools on patients, with a rate of 
39.47% and 28.94% respectively. A few nurses reported no to low comfort levels, with a rate of 
6.57% and 10.52% respectively, while 14.47% reported feeling neither comfortable nor 
uncomfortable in administering BH screening tools to stroke patients. A high number of nurses 
also reported moderate to high comfort levels in answering questions from patients and family 
members as to why BH screening tools are being administered, with a rate of 36.84% and 
32.89% respectively. A few nurses reported no to low comfort levels, with a rate of 5.26% and 
9.21% respectively, while 15.78% reported feeling neither comfortable nor uncomfortable in 
answering questions from patients and family members as to why BH screening tools are being 
administered. Nurses who responded to the pre-live survey reported moderate to high confidence 
in the value of BH screening tools on patients as it relates to stroke patient outcomes, with a rate 
of 43.42% and 56.57% respectively. A high number of nurses reported that they either somewhat 
agree or agree on recommending the use of BH screening tools on stroke patients, with a rate of 
51.31% and 48.68% respectively, while 6.57% reported being unsure whether to recommend or 
not. Additionally, 30.3% of nurses admitted that they have reported to a provider that a stroke 
patient may require a BH consult or intervention at one point. Majority of the nurses reported 
observing behavioral changes from stroke patients 2 to 3 days, post-hospital admission.  
At month 1 of project go-live,  a total of 10 stroke patients (4 in the MSU and 6 in the 
ARU) who did not have moderate to severe aphasia or facial palsy were administered the PHQ-2. 
The average LOS for the MSU and ARU were 5.2 and 10.2 days respectively. Only 1 patient met 
the criteria for PHQ-9 screening. The patient scored less than 10 in the PHQ-9 and was 
considered not depressed at the time of screening. 
DEPRESSION SCREENING AND EARLY INTERVENTION  40 
 
At month 2 of project go-live,  a total of 10 stroke patients (5 in the MSU and 5 in the 
ARU) who did not have moderate to severe aphasia or facial palsy were administered the PHQ-2. 
The average LOS for the MSU and ARU were 5.0 and 10.6 days respectively. Two patients met 
the criteria for PHQ-9 screening and scored 10 or more, and were considered as depressed at the 
time of screening. Both patients were started on a low-dose SSRI.  
At month 3 of project go-live,  a total of 7 stroke patients (4 in the MSU and 3 in the 
ARU) who did not have moderate to severe aphasia or facial palsy were administered the PHQ-2. 
The average LOS for the MSU and ARUU were 6.2 and 10.2 days respectively. Only 1 patient 
met the criteria for PHQ-9 screening and scored 10 or more. The patient was considered as 
depressed at the time of screening. The patient was started on a low-dose SSRI.  
A total number of 82 nurses completed the post-live survey. A high number of nurses 
expressed moderate to high comfort levels in administering BH screening tools on stroke 
patients, with a rate of 36.58% and 47.56% respectively. A few nurses reported no to low 
comfort levels, with a rate of 3.65% and 2.43% respectively, while 9.75% reported feeling 
neither comfortable nor uncomfortable in administering BH screening tools to stroke patients. A 
high number of nurses also reported moderate to high comfort levels in answering questions 
from patients and family members as to why BH screening tools are being administered, with a 
rate of 34.14% and 47.56% respectively. A few nurses reported no to low comfort levels, both 
with a rate of 2.43%, while 13.41% reported feeling neither comfortable nor uncomfortable in 
answering questions from patients and family members as to why BH screening tools are being 
administered. Nurses who responded to the post-live survey reported moderate to high 
confidence in the value of BH screening tools on patients as it relates to stroke patient outcomes, 
with a rate of 47.56% and 52.43% respectively. A high number of nurses reported that they 
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either somewhat agree or agree on recommending the use of BH screening tools on stroke 
patients, with a rate of 46.34% and 53.65% respectively, while 3.65% reported being unsure 
whether to recommend or not. Additionally, 30.48% of nurses admitted that they have reported 
to a provider that a stroke patient may require a BH consult or intervention at one point. Majority 
of the nurses reported observing behavioral changes from stroke patients 2 to 3 days, post-
hospital admission. 
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Section IV: Results 
Program Evaluation and Outcomes 
Several numerical changes were noted after comparing the results of the pre-live with the 
post-live staff surveys. For the reported comfort levels in administering BH screening tools on 
stroke patients: (a) there was a decrease of 2.92% in nurses feeling uncomfortable, (b) there was 
a decrease of 9.08% in nurses feeling somewhat uncomfortable, (c) there was a decrease of 
4.72% in nurses neither feeling comfortable nor uncomfortable, (d) there was a decrease of 
2.89% in nurses feeling somewhat comfortable, while (e) there was an increase 18.52% in nurses 
feeling comfortable. For the reported comfort levels in answering questions from patients and 
family members as to why the BH screening tool was being administered: (a) there was a 
decrease of 2.85% in nurses feeling uncomfortable, (b) there was a decrease 6.78% in nurses 
feeling somewhat uncomfortable, (c) there was a decrease of 2.37% in nurses feeling neither 
comfortable nor uncomfortable, (d) there is a decrease of 2.7% in nurses feeling somewhat 
comfortable, while (e) there was an increase of 14.67% in nurses feeling comfortable. For the 
reported confidence in the value of administering BH screening tools on stroke patients: (a) there 
was an increase of 4.14% in nurses reporting some confidence, and (b) there was a decrease of 
4.14% in nurses reporting confidence. For recommending the use of BH screening tools on 
stroke patients: (a) there was a decrease of 2.92% in nurses who would neither recommend nor 
not recommended, (b) there was an increase of 4.97% in nurses who would recommend, while 
(c) there was an increase of 21.02% in nurses who would recommend. Additionally, BH changes 
are still observed by nurses 2 to 3 days post-hospital admission. There was no significant change 
in reporting rate by nurses for PSD interventions to providers. 
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 After reviewing the total number of admitted stroke patients for the 3 month period of 
project go-live, a total of 27 patients were identified as not having moderate to severe aphasia of 
facial palsy and were administered the PHQ-2 screening tool. Five out of these 27 patients scored 
3 or more on the PHQ-2 and were administered the PHQ-9 screening tool. Only 3 of these 5 
patients scored 10 or more on the PHQ-9 and considered depressed. The number of positive PSD 
screens for post-stroke patients is significantly below the expected rate of 33%, with the actual 
rate being at 11%. All patients with positive PSD screens were afforded early intervention and 
were started on a low-dose SSRI. Additionally, all admitted stroke patients, regardless of their 
PHQ scores were provided informal CBT sessions by stroke nurses, through the hospitals stroke 
education session held during the weekends, which involved topics like “how to cope with 
changes in feelings after having a stroke”.  
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Section V: Discussion 
Summary 
 Despite the low volume of stroke patients admitted in the hospital during the 3-month 
period, the project was moderately successful on multiple levels. The project produced the 
intended outcomes of cost-effective staff training and education on the timely administration of 
PSD screening measures and intended pharmacological interventions. It was able to moderately 
raise nurses’ comfort levels in the administration of BH screening questions and answering 
questions related to its use. Additionally, nurses reported moderate increase in confidence the 
overall clinical utility of PSD screening as part of the stroke care process. As a disruptive 
innovation, it also exposed organizational stakeholders to the benefits of considering small tests 
of change. The project was implemented during a period of high leadership turnover and when 
the organization had just recently undergone its PSC re-certification, the project exemplified a 
no-risk, low-key, and moderate-paced implementation. Overall success was dependent on the 
widespread acceptance and support of all involved stroke care areas and enthusiastic 
participation of resources and stroke care nurses. And although the project’s success on proving 
improvement of stroke outcomes as it relates to timely screening and intervention of PSD was 
considered low, due to several factors and limitations of the project, there appears to be a strong 
link between good communication, good training, and staff compliance to small tests of change 
aimed at improving patient care.  
Relation to Other Evidence 
Experimental Research 
 Kronenberg, Gertz, Heinz, and Endres (2014) conducted a translational research on 
experiments conducted in modeling PSD in rodents via a variety of approaches. The researchers 
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aimed to investigate short-term end points of acute stroke lesions and its relevance to the 
development of PSD. The potential use of 5-hydroxytryptaminergic antidepressants as a 
pharmacologic intervention for PSD was also explores. Four neurobiological changes in the 
brain that contribute to behavioral changes and depressive-like symptoms post-stroke among 
rodents (and other mammals) were identified: (a) the ability of the brain to capacity in building 
new glia (neuroplasticity), (b) impaired neutropin signaling with decrease brain-derived 
neurotropic factors (BDNF) concentrations seen post-mortem in suicide victims and patients 
with mood disorders,(c) an increase in pro-inflammatory cytokines which is associated with 
decrease reactivity from the social and physical environment, and (d) the rupturing of critical 
neural pathways (neurodegeneration). The corrective actions of antidepressants and other mood 
stabilizing agents after a stroke at the brain’s cellular and molecular levels were also validated. 
The researchers concluded that outcomes in rodent stroke research may be of great value for 
bridging the gap between clinical and other experimental perspectives in human stroke research. 
Research outside the United States 
Stroke and post-stroke complications are a growing public health concern worldwide. It 
is estimated that frequency of reported PSD cases around the world range from 20% to 60% 
(Ojagbemi, Akinyemi, & Baiyewu, 2014). Outside the US, several studies have been conducted 
to determine the frequency and predictors of PSD. Ojagbemi et al. (2014), conducted a study on 
130 stroke survivors in Nigeria undergoing rehabilitation over a 6-month period matched with a 
control group of 130 healthy subjects, 60 males and 70 females. Most of the participants had 
medical co-morbidities, such as systemic hypertension, and nearly one-quarter were either had a 
history of alcohol abuse. Literacy was low, with 104 participants only having up to 6 years of 
formal education while, while the remaining had none. Participants were referred by their 
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primary care physicians (PCP). The aim of the study is to determine the frequency and predictors 
of a Major Depressive Disorder (MDD) according to the DSM IV criteria using standardized 
assessments in developing countries, such as Nigeria. 
The Schedules for Clinical Assessment in Neuropsychiatry (SCAN) was used in the 
diagnosis of a depressive disorder. At least 5 symptoms lasting 2 weeks or more meant that the 
patient was depressed. The researchers reported that 41.5% of the participants met the criteria for 
MDD post-stroke. The researchers believe that the morbidity in reported PSD may be associated 
with the following factors: (a) mild stroke patients may not undergo rehabilitation or follow 
through with referrals, (b) inefficient treatment of stroke at its acute phase, (c) a large proportion 
of patients may present with traditional or sociocultural beliefs about stroke (e.g. faith healers, 
etc.), and (d) limited access to health care services. The researchers concluded that although the 
association between socio-economic risk factors for PSD were not directly studied,  the social 
economic changes in developing countries may also contribute the bi-directional relationship 
between disability and depression. 
Non-Pharmacologic Treatments 
 The most prevalent intervention for post-stroke neuropsychiatric disorders are 
pharmacological agents. Currently, there is no universally accepted non-pharmacological 
treatment for PSD. The reactive aspect of stroke such as functional impairment and PSD has 
been subject to much debate. However, it has been suggested that PSD arise from the patient’s 
inadequate adjustment to the consequences of the stroke and significance to loss of functioning. 
Behavior change potential for stroke patients is limited. The traditional CBT approach of 
modifying irrational, self-defeating and other negative thoughts do not typically work for stroke 
patients who have sensory, motor, and cognitive impairments. Kootker et al. (2015) proposed a 
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new psychological treatment protocol in the form of a stroke-specific cognitive behavioral 
therapy (CBT). The intervention supports the inclusion of occupational and movement during 
therapy sessions by modifying existing CBT intervention for chronic disease to be stroke-
specific.  
The researchers conducted a pilot study on 5 patients and integrated 5 psychological 
approaches to CBT: (a) enhancement of motivation for behavioral change through motivational 
interviewing, (b) promotion of grief resolution, (c) explanation of the relationship between 
thought, feelings, and actions (Cognitive deficits adaptation), (d) selective optimization with 
compensation through occupational and movement therapy, and (e) executive skills training 
through relaxation techniques. The aim of the intervention is to improve self-efficacy by 
providing cognitive tools to effect positive behavioral change. Participants attended 15-16 
individual CBT sessions, jointly facilitated by a psychologist and an occupational therapist. 
Although the outcome of the study was not clearly defined, the researchers agree that the 
proposed intervention is innovative through its inclusion of occupational and movement therapy 
and concurrently addressing post-stroke anxiety complaints. 
Limitations 
 Because of the scope and constraints of the project, the project manager acknowledges 
several short-comings. The project limitations identified are the following: 
 The number of admitted stroke patient who met criteria for PSD screening was low. A 
large population is required to sufficiently measure the clinical utility of revising current 
stroke care processes to include PSD screening.  
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 The heterogeneous entry of stroke patients in to the hospital, either through the ED or via 
inter-facility transfer and directly in to the ARU, also meant that stroke patients screened 
for PSD are at varying stages post-stroke. 
 The chosen screening tools, the PHQ-2 and PHQ-9, are language-based measures 
necessitating the exclusion of patients with moderate to severe aphasia and facial palsy - 
patients that may also screen positive for depression had a non-language based tool was 
administered. 
 Only two treatment modalities / interventions were administered for positive screens: (a) 
SSRIs and (b) pseudo-CBT. 
 SSRIs, the first-line agent for PSD and other mood disorders typically take 4 or more 
weeks to take effect. The scope of the project did not involve measuring the efficacy of 
pharmacologic interventions for PSD after hospitalization. 
 Cognitive decline and other post-stroke deficits are continuously monitored at each shift 
through the use of the NIHSS. However, PSD screening was done only at one point (72 
hours after admission) and not at multiple points during the patient’s hospitalization.  
Conflict of Interest 
 The project manager acknowledges that there are no financial or personal relationships 
between him and others involved that might bias this project. 
Interpretation  
 Although this project was ideally suited for implementation on a much larger scale that 
would encompass all 4 identified stroke care areas (ED, MSU, ICU, and ARU), it was successful 
implemented in only the two high volume units, the MSU and ARU. Despite the lack of a 
clinical alert (in the EHR) for nurses to screen, and varying levels of reported comfort in 
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administering BH screening tools and answering questions from patients and family members as 
to why the BH tool is being administered, compliance with PSD screening was high. The project 
manager assumes that high compliance was affected by the following: (a) stroke is a hospital 
core measure and is already a closely monitored condition, (b) effective teaching in the use of the 
screening tool, and (c) easy administration / use of the chosen screening measure. 
Conclusions  
The biological and psychosocial theories of PSD can be an excellent guide in determining 
higher risk populations and providing a timeline on when to observe for depressive symptoms. 
The neurochemical changes in the brain provide an excellent framework for pharmacologic 
management of depressive symptoms and the efficacy of SSRIs in treating PSD are well 
documented. Although, tests to determine lesion location are part of conventional stroke care, the 
inclusion of additional invasive procedures and tests to assess for neurochemical and other 
microenvironment changes in the brain can prove too costly and may add to the stroke patient’s 
distress. Rather than inflating the cost of hospitalization and exposing the patient to several 
invasive procedures, the administration of a simple clinical tool for PSD screening is more cost-
effective and ethical. 
Nurses play an important role in all the phases of stroke care and stages of stroke 
recovery. They are at key position in detecting depressive symptoms and advocating for BH 
interventions for stroke patients. Although PSD screening is only recommended for PSCs, the 
inclusion of validated depression screening measure with conventional stroke care processes 
should be integrated in all levels of stroke care to enable early detection, treatment, and 
improving overall stroke outcomes.  
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Section VI: Other Information 
Funding 
Funding for this project and any future publication was directly provided by the project 
manager. Incidental support activities such as staff education and training by resource nurses are 
not included in the project budget and were provided by the project site volunteers and 
organizational leaders. 
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Appendix A 
Evidence-Based Change of Practice Project Checklist 
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Appendix C 
Work Breakdown Structure 
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Appendix D 
Project Resource Requirements Table 
Work Package WBS ID Activity Predecessor 
Duration in 
Weeks 
Review of Evidence 1.1 Review PSD Guidelines N/A 4 
Review of Evidence 1.1.1 
Review PSD Etiology 
Literature 
1.1 6 
Review of Evidence 1.1.2 
Review PSD Screening 
Literature 
1.1 6 
Review of Evidence 1.1.2.1 
Identify Validated 
Depression Screening Tool 
1.1.2 2 
Workflow Mapping 1.2 
Map current stroke care 
workflow 
1.1 2 
Gap Analysis 1.2.1 Perform Gap Analysis 1.2 1 
Workflow Mapping 1.2.2 
Map proposed PSD 
screening workflow 
1.2.1 2 
Pre Go-live Survey 1.3 Conduct pre-live survey 1.2.1 2 
Pre Go-live Survey 1.3.1 Review survey results 1.3 1 
Training 1.4 Create tool kit 1.3.1 1 
Training 1.4.1 Train resource nurses 1.4 1 
Testing 1.5 Identify high volume units 1.4 1 
Testing 1.5.1 Pilot in ED and ICU 1.5 4 
Testing 1.5.2 Pilot in MSU and ARU 1.5 4 
Training 1.6 Train stroke care nurses 1.4 4 
Screening Tool 1.7 Screening tool printing 1.1.2.1 1 
Screening Tool 1.7.1 Assemble resource binder 1.7 1 
Project Go-live 1.8 Go-live on stroke care units 1.6 12 
Project Go-live 1.8.1 Data Mining 1.8 8 
Project Go-live 1.8.2 Project Evaluation 1.8.1 8 
Project Go-live 1.8.3 
Present findings to 
organizational leadership 
1.8.2 1 
Post Go-live Survey 1.9 Conduct post-live survey 1.8 2 
Write-up 2.1 
Integrate findings into DNP 
paper 
1.9 6 
Write-up 2.2 Submit DNP with revisions 2.1 2 
Write-up 2.3 Present project to committee 2.2 1 
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Appendix E 
Gantt Chart 
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Literature review.                      
Identification of 
Project Site. 
                     
Identification of 
project sponsor. 
                     
IRB Clearance.                      
Meet with MSU 
Nurse Manager. 
                     
Meet with ARU 
Nurse Manager. 
                     
Meet with Stroke 
Coordinator. 
                     
Identification of 
resource nurses. 
                     
Pre-live survey.                      
Testing (ED & ICU)                      
Identification of new 
project sponsor. 
                     
Testing (MSU & 
ARU) 
                     
Staff training.                      
Submission of 
project prospectus. 
                     
Identification of new 
project sponsor. 
                     
Project go-Live.                      
Data mining.                      
Post-live survey.                      
Present findings to 
hospital leadership. 
                     
Submission of DNP 
paper. 
                     
Submission of DNP 
paper with revisions. 
                     
Present project to 
committee. 
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Appendix F 
Financial Report 
Expenses Budget Actual Var. 
Direct Expenses      
 Printing / Copying Services *  $300.00    
 Transportation Expense      
  Gas $150.00     
  Parking (Student rate at $8 per day) $320.00 $470.00    
 Volunteer Meals  $100.00    
 Catering Costs (Day of project go-live)  $300.00 $1080.00 $978.50 9.39% 
Indirect Expense      
 Office Supplies Expense **  $50.00    
 Other (Unforeseen) Expenses  $300.00    
 Token of Appreciation  
(for project sponsor and resource nurses) 
 $150.00 $500.00 $536.75 -7.35% 
Total Direct & Indirect Expenses   $1580.00 $1515.25 4.09% 
Estimated Opportunity Costs ***      
 Project hours of project manager  
(535 hours at $62.56 per hour) 
  $33469.60   
 Project hours of resource nurses ($56 per hour)      
  Resource nurse A (80 hours)  $4480.00    
  Resource nurse B (80 hours)  $4480.00    
  Resource nurse C (40 hours)  $2240.00    
  Resource nurse D (40 hours)  $2240.00 $13440.00   
  Total Opportunity Costs   $46909.60   
        
* Include binding costs for resource manuals.     
** Include papers, folders, and other office supplies.     
*** For reference only. Not part of the budget.     
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Appendix G 
Workflow Map 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stroke patient admitted to the unit. 
RN completes the admission database and 
NIHSS. 
Patient is logged into the stroke census. 
Patient is 72 hours post-admission. 
Patient rates 0 to 2 for 
presence of facial palsy? 
Patient rates 0 to 1 for 
presence of aphasia? 
RN continues with routine stroke care. 
RN administers the PHQ-2. 
Patient rates 3 or more on 
the PHQ-2? 
RN administers the PHQ-9. 
RN documents the pHQ-2 in the EHR, 
files the completed form in the paper, 
and continues with routine stroke care. 
Patient rates 10 or more 
on the PHQ-9? 
RN files the completed questionnaires, 
documents the PHQ-9 score, and notifies 
attending provider. 
Attending provider reviews the patient’s 
PHQ-9 score and decides on appropriate 
BH intervention (e.g. BH consult, start 
on antidepressant, etc.). 
YES 
YES 
NO 
NO 
NO 
NO 
YES 
YES 
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Appendix H 
Patient Health Questionnaire-2 
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Appendix I 
Patient Health Questionnaire-9 
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Appendix J 
National Institutes for Health Stroke Scale (Items 1a-3) 
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Appendix K 
National Institutes for Health Stroke Scale (Items 4-9) 
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Appendix L 
National Institutes for Health Stroke Scale (Items 10-11) 
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Appendix M 
SWOT Analysis 
Strengths  Weaknesses 
 TJC-certified PSC. 
 
 Stroke certified nurses. 
 
 Clinical nurse ladder program. 
 
 One of the few hospitals with an 
inpatient BHU and onsite BH 
providers. 
 
 One of the few hospitals with an 
inpatient ARU. 
 Small urban hospital with several 
neighboring GACHs. 
 
 Poor NIHSS compliance by staff. 
 
 Lack of a stroke coordinator. 
 
 Location (Tenderloin area). 
 
 Lengthy process for approval of EHR 
build requests. 
 
 Lack of BH screening measures in the 
current EHR system. 
 
Opportunities  Threats 
 Utilization of BH consults on 
depressed stroke patients. 
 
 Staff nurse III/IVs involvement in QI 
projects. 
 
 Quality improvement on current 
stroke care processes through the 
inclusion of PSD screening and 
intervention(s). 
 
 Staff education on PSD etiology, 
onset, signs and symptoms, treatment, 
and recovery. 
 
 Standardization of depression 
screening documentation. 
 
 Changes in organizational leadership. 
 
 Other designated PSCs and CSCs in the 
area. 
 
 Change fatigue and change resistance at 
the staff level. 
 
 Concurrent Q! projects competing for 
resources. 
 
` 
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Appendix N 
Pre-live Project Survey Questionnaire 
Survey Questions 
 
Disagree 
Somewhat 
Disagree 
Neither 
Agree nor 
Disagree 
Somewhat 
Agree Agree 
Total % 
Rating Scale 1 2 3 4 5   
        
I am comfortable in administering 
behavioral health screening tools 
on stroke patients. 
       
        
I am comfortable in answering 
questions from patients and 
family members as to why 
behavioral health screening tools 
are being administered. 
       
        
I believe in the value of 
administering behavioral health 
screening tools on patients as it 
relates to stroke patient outcomes. 
       
        
I would recommend the use of 
behavioral health screening tools 
on stroke patients. 
       
        
Total        
 
At what day after admission do 
you typically observe behavioral 
changes (e.g. irritable, crying 
spells, socially withdrawn, etc.) 
from stroke patients? Please select 
one. 
□ Did not observe any 
behavioral changes. 
□ Same day after admission. 
□ 1 day after admission. 
□ 2 days after admission. 
□ 3 days after admission. 
□ 4 days after admission. 
□ 5 days or more after                            
admission. Please specify: ___ 
Have you ever reported to a 
provider that a post-stroke patient 
may require a behavioral health 
consult or intervention? 
□ Yes 
□ No 
Comments:  
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Appendix O 
Post-live Project Survey Questionnaire 
Survey Questions 
 
Disagree 
Somewhat 
Disagree 
Neither 
Agree nor 
Disagree 
Somewhat 
Agree Agree 
Total % 
Rating Scale 1 2 3 4 5   
        
I am comfortable in administering 
behavioral health screening tools 
on stroke patients. 
       
        
I am comfortable in answering 
questions from patients and 
family members as to why 
behavioral health screening tools 
are being administered. 
       
        
I believe in the value of 
administering behavioral health 
screening tools on patients as it 
relates to stroke patient outcomes. 
       
        
I would recommend the use of 
behavioral health screening tools 
on stroke patients. 
       
        
Total        
Have you ever reported to a 
provider that a post-stroke patient 
may require a behavioral health 
consult or intervention? 
□ Yes 
□ No 
At what day after an intervention 
(e.g. antidepressants, brief 
psychotherapy, etc.) had been 
initiated did you observe 
improvement in the patient’s 
behavior? Please select one. 
□ Did not observe any 
improvement in behavior. 
□ Same day. 
□ After 1 day. 
□ After 2 days 
□ After 3 days. 
□ After 4 days. 
□ 5 days or more after                            
intervention has been started. 
Please specify: ___ 
Comments:  
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Appendix O 
Staff Survey Results 
Pre-Live Survey Results 
Duration: 4 weeks     Number of Respondents: 76 
 1 % 2 % 3 % 4 % 5 % 
I am comfortable in administering behavioral 
health screening tools on stroke patients. 
5 6.57 8 10.52 11 14.47 30 39.47 22 28.94 
I am comfortable in answering questions from 
patients and family members as to why 
behavioral health screening tools are being 
administered. 
4 5.26 7 9.21 12 15.78 28 36.84 25 32.89 
I believe in the value of administering 
behavioral health screening tools on patients as 
it relates to stroke patient outcomes. 
0 0 0 0 0 0 33 43.42 43 56.57 
I would recommend the use of behavioral 
health screening tools on stroke patients. 
0 0 0 0 5 6.57 39 51.31 37 48.68 
Have you ever reported to a provider that a 
post-stroke patient may require a behavioral 
health consult or intervention? 
Yes 23 % 30.3  No 53 % 69.7 
At what day after admission do you typically 
observe behavioral changes (e.g. irritable, 
crying spells, socially withdrawn, etc.) from 
stroke patients? Please select one. 
 
Never % Same 
day 
% After  
1 day 
% After  2 
days 
% After  3 
days 
% After  4 
days 
% 
After  
5 days 
or > % 
0 0 4 5.26 5 6.57 17 22.36 36 47.36 10 13.15 4 5.26 
 
 
Post-Live Survey Results 
Duration: 4 weeks     Number of Respondents: 82 
 1 % 2 % 3 % 4 % 5 % 
I am comfortable in administering behavioral 
health screening tools on stroke patients. 
3 3.65 2 2.43 8 9.75 30 36.58 39 47.56 
I am comfortable in answering questions 
from patients and family members as to why 
behavioral health screening tools are being 
administered. 
2 2.43 2 2.43 11 13.41 28 34.14 39 47.56 
I believe in the value of administering 
behavioral health screening tools on patients 
as it relates to stroke patient outcomes. 
0 0 0 0 0 0 39 47.56 43 52.43 
I would recommend the use of behavioral 
health screening tools on stroke patients. 
0 0 0 0 3 3.65 38 46.34 44 53.65 
Have you ever reported to a provider that a 
post-stroke patient may require a behavioral 
health consult or intervention? 
Yes 25 % 30.48  No 57 % 69.51 
At what day after an intervention (e.g. 
antidepressants, brief psychotherapy, etc.) 
had been initiated did you observe 
improvement in the patient’s behavior? 
Please select one. 
 
Never % Same 
day 
% After  1 
day 
% After  2 
days 
% After  3 
days 
% After  4 
days 
% 
After  5 
days or 
> % 
0 0 8 9.75 6 7.31 19 23.17 34 41.46 12 14.63 3 3.65 
 
DEPRESSION SCREENING AND EARLY INTERVENTION  72 
 
Appendix P 
Screening and Intervention Results 
Testing (1 Month) 
Stroke 
Care Unit 
# of   
Stroke 
Patients 
Pre-PSD 
Screening 
NIHSS  
# of    
PHQ-2 
Score > 3 
# of   
PHQ-9 
Score > 10 
# of            
(+) PSD 
Intervention 
# of   
FALL 
Average 
LOS 
Pre-DC 
NIHSS 
# of       
Readmits 
ED 3 N/A 0 0 0 0 No data N/A 0 
ICU 3 N/A 0 0 0 0 6.2 N/A 0 
MSU 5 N/A 0 0 0 0 4.9 N/A 0 
ARU 4 16 1 0 0 0 10.1 12 0 
 
Project Live Month 1 
Stroke 
Care Unit 
# of   
Stroke 
Patients 
Pre-PSD 
Screening 
NIHSS  
# of    
PHQ-2 
Score > 3 
# of   
PHQ-9 
Score > 10 
# of            
(+) PSD 
Intervention 
# of   
FALL 
Average 
LOS 
Pre-DC 
NIHSS 
# of       
Readmits 
MSU 4 N/A 0 0 0 0 5.2 N/A 0 
ARU 6 14 1 0 0 0 10.2 12 0 
 
Project Live Month 2 
Stroke 
Care Unit 
# of   
Stroke 
Patients 
Pre-PSD 
Screening 
NIHSS  
# of    
PHQ-2 
Score > 3 
# of   
PHQ-9 
Score > 10 
# of            
(+) PSD 
Intervention 
# of   
FALL 
Average 
LOS 
Pre-DC 
NIHSS 
# of       
Readmits 
MSU 5 18 1 1 1 0 5.0 13 0 
ARU 5 15 1 1 1 0 10.6 12 0 
 
Project Live Month 3 
Stroke 
Care Unit 
# of   
Stroke 
Patients 
Pre-PSD 
Screening 
NIHSS  
# of    
PHQ-2 
Score > 3 
# of   
PHQ-9 
Score > 10 
# of            
(+) PSD 
Intervention 
# of   
FALL 
Average 
LOS 
Pre-DC 
NIHSS 
# of       
Readmits 
MSU 4 N/A 2 0 0 0 6.2 N/A 0 
ARU 3 15 1 1 1 0 10.2 10 0 
 
MSU Results Summary 
Stages 
# of   
Stroke 
Patients 
Pre-PSD 
Screening 
NIHSS  
# of    
PHQ-2 
Score > 3 
# of   
PHQ-9 
Score > 10 
# of            
(+) PSD 
Intervention 
# of   
FALL 
Average 
LOS 
Pre-DC 
NIHSS 
# of       
Readmits 
Test 5 N/A 0 0 0 0 4.9 N/A 0 
Month 1 4 N/A 0 0 0 0 5.2 N/A 0 
Month 2 5 18 1 1 1 0 5.0 13 0 
Month 2 4 N/A 2 0 0 0 6.2 N/A 0 
 
ARU Results Summary 
Stages 
# of   
Stroke 
Patients 
Pre-PSD 
Screening 
NIHSS  
# of    
PHQ-2 
Score > 3 
# of   
PHQ-9 
Score > 10 
# of            
(+) PSD 
Intervention 
# of   
FALL 
Average 
LOS 
Pre-DC 
NIHSS 
# of       
Readmits 
Test 4 16 1 0 0 0 10.1 12 0 
Month 1 6 14 1 0 0 0 10.2 12 0 
Month 2 5 15 1 1 1 0 10.6 12 0 
Month 2 3 15 1 1 1 0 10.2 10 0 
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Appendix Q 
Training Handouts 
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Appendix R 
Betty Neuman’s System Model 
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Appendix S 
Evidence Table 
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Appendix T 
Cost Savings Table 
PSD PATIENTS IN THE MSU WHO RECEIVED PHARMACOLOGIC INTERVENTION  
 MEDI-CAL DRG PROJECT SITE  
LOS DRG BASE RATE/DAY # (+) CASES MSU LOS ∆ LOS SAVINGS 
MONTH 1 7.65 $17415 $2276.47 0 N/A N/A N/A 
MONTH 2 7.65 $17415 $2276.47 1 5.0 2.65 $6032.64 
MONTH 3 7.65 $17415 $2276.47 0 N/A N/A N/A 
 
PSD PATIENTS IN THE ARU WHO RECEIVED PHARMACOLOGIC INTERVENTION  
 MEDI-CAL DRG PROJECT SITE  
LOS DRG BASE RATE/DAY # (+) CASES MSU LOS ∆ LOS SAVINGS 
MONTH 1 14.75 $10410 $705.76 0 N/A N/A N/a 
MONTH 2 14.75 $10410 $705.76 1 10.6 4.15 $2928.90 
MONTH 3 14.75 $10410 $705.76 1 10.2 4.55 $3211.21 
 
PSD PATIENTS IN THE MSU WHO RECEIVED PHARMACOLOGIC INTERVENTION  
 MEDI-CAL DRG PROJECT SITE (MSU LOS X 
1.71) – MSU 
LOS LOS DRG BASE RATE/DAY # (+) CASES MSU LOS SAVINGS 
MONTH 1 7.65 $17415 $2276.47 0 N/A N/A N/A 
MONTH 2 7.65 $17415 $2276.47 1 5.0 3.55 $8079.8 
MONTH 3 7.65 $17415 $2276.47 0 N/A N/A N/A 
 
PSD PATIENTS IN THE ARU WHO RECEIVED PHARMACOLOGIC INTERVENTION  
 MEDI-CAL DRG PROJECT SITE (ARU LOS X 
1.71) – ARU 
LOS LOS DRG BASE RATE/DAY # (+) CASES MSU LOS SAVINGS 
MONTH 1 14.75 $10410 $705.76 0 N/A N/A N/A 
MONTH 2 14.75 $10410 $705.76 1 10.6 7.526 $5311.54 
MONTH 3 14.75 $10410 $705.76 1 10.2 7.242 $5111.11 
 
COST SAVINGS $30675.2 
LESS: ACTUAL DIRECT AND INDIRECT EXPENSES $1515.25 
NET SAVINGS  OVER A 3-MONTH PERIOD $29159.95 
 
 
